Clinical trial / 2005
Curcumin treatment showed preliminary improvements in small pilot trial of inflammatory bowel disease.
Ten patients with inflammatory bowel disease received a pure curcumin preparation in an open-label pilot study. All five patients with ulcerative proctitis improved, with four reducing concurrent medications. Additionally, four of five patients with Crohn's disease had lower Crohn's Disease Activity Index scores and sedimentation rates.
- Study type
- Uncontrolled clinical trial
- Who was studied
- 10 patients (5 with ulcerative proctitis, 5 with Crohn's disease)
- What was measured
- Clinical symptoms, medication usage, CDAI scores, and sedimentation rates
THE PAPER
Curcumin therapy in inflammatory bowel disease: a pilot study.
Holt PR, Katz S, Kirshoff R. Dig Dis Sci, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.